PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF POST-CHEMOTHERAPY NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN TREATMENT WITH BVD (BENDAMUSTINE BORTEZOMIB-DEXAMETHASONE)

被引：0
|
作者：
Cerchione, C. [1 ]
Nappi, D. [1 ]
Salvatore, D. [1 ]
Migliaccio, I. [1 ]
Pane, F. [1 ]
Catalano, L. [1 ]
机构：
[1] Au Federico Ii, Hematol Ematol & Trapianto, Naples, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1330
引用
收藏
页码：550 / 551
页数：2
相关论文
共 50 条
  • [1] PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF POST-CHEMOTHERAPY NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Basile, S.
    Russo, V.
    Seneca, E.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2014, 99 : 754 - 755
  • [2] PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF THERAPY RELATED NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN TREATMENT WITH POMALIDOMIDE-DEXAMETHASONE
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Picardi, M.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S129 - S129
  • [3] Pegfilgrastim versus Filgrastim in the Management of Therapy-Related Neutropenia in Relapsed and Refractory Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S255 - S256
  • [4] Pegfilgrastim Versus Filgrastim in the Management of Therapy-Related Neutropenia in Relapsed and Refractory Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone
    Cerchione, Claudio
    Nappi, Davide
    Pane, Fabrizio
    Catalano, Lucio
    BLOOD, 2018, 132
  • [5] Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
    Cerchione, Claudio
    Catalano, Lucio
    Peluso, Ilaria
    Nappi, Davide
    Di Perna, Maria
    Salvatore, Dalila
    Migliaccio, Ilaria
    Picardi, Marco
    Pane, Fabrizio
    SUPPORTIVE CARE IN CANCER, 2016, 24 (12) : 4835 - 4837
  • [6] MANAGING NEUTROPENIA BY PEGFILGRASTIM IN PATIENTS AFFECTED BY RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE
    Cerchione, C.
    Catalano, L.
    Peluso, I.
    Nappi, D.
    Di Perna, M.
    Picardi, M.
    Pane, F.
    HAEMATOLOGICA, 2016, 101 : S118 - S118
  • [7] Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
    Claudio Cerchione
    Lucio Catalano
    Ilaria Peluso
    Davide Nappi
    Maria Di Perna
    Dalila Salvatore
    Ilaria Migliaccio
    Marco Picardi
    Fabrizio Pane
    Supportive Care in Cancer, 2016, 24 : 4835 - 4837
  • [8] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Nappi, D.
    Basile, S.
    Marano, L.
    Peluso, I
    Simeone, L.
    Vitagliano, O.
    Romano, A.
    Palmieri, S.
    Rocco, S.
    Pane, F.
    Ferrara, F.
    HAEMATOLOGICA, 2018, 103 : 38 - 38
  • [9] Bendamustine-Bortezomib-Dexamethasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience
    Cerchione, Claudio
    Catalano, Lucio
    Pareto, Anna Emanuele
    Basile, Santina
    Marano, Luana
    Peluso, Ilaria
    Simeone, Luigia
    Vitagliano, Orsola
    Palmieri, Salvatore
    Rocco, Stefano
    Ferrara, Felicetto
    Pane, Fabrizio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E60 - E61
  • [10] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Nappi, D.
    Di Perna, M.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    HAEMATOLOGICA, 2017, 102 : 138 - 139
12345